James W. Young, MD

About Me

I provide allogeneic (donor-provided) blood or marrow stem cell transplants for the treatment of leukemias, lymphomas, and selected solid tumors in adult patients. In the laboratory, I am investigating ways to use dendritic cells — a specific type of white blood cell — to activate the immune system to destroy cancer cells and viruses. Part of my research involves understanding how immature blood cells develop into dendritic cells and how dendritic cells interact with other immune cells, including T cells. I am also studying the effectiveness of using dendritic cells to reduce the risk of graft-versus-host disease in transplant patients (a condition in which T cells from the donor marrow attack the recipient’s tissues). My colleagues and I are also evaluating the use of dendritic cell-based vaccines against cancer.

Read more
  • Clinical Expertise: Bone Marrow Transplantation; Hematology and Hematologic Malignancies; Immunology and Immunotherapy
  • Languages Spoken: English
  • Education: MD, Vanderbilt University School of Medicine
  • Residencies: The Johns Hopkins Hospital
  • Fellowships: The New York Hospital/Cornell Medical Center; Cornell University Medical College; Hospital for Special Surgery; The Rockefeller University
  • Board Certifications: Internal Medicine; Medical Oncology; Hematology; Rheumatology

My Research

View my lab

See James W. Young’s laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of James W. Young’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.